- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03963180
Coffee Consumption for Intestinal Function Recovery After Laparoscopic Gynecologic Surgery
Coffee Consumption for Intestinal Function Recovery After Laparoscopic Gynecologic Surgery: a Randomized Controlled Trial
Minimally invasive surgery (MIS) has revolutionized women's healthcare. Laparoscopy is an excellent route of MIS. Today, laparoscopic surgery is one of the major procedure in the management of a gynecologic disease. It has revealed benefits of decreased morbidity, earlier discharged, and quicker return to normal daily activities, and shorter hospital when compared to abdominal approach.
Postoperative ileus (POI) defined as an uncomplicated ileus occurring following surgery, resolving spontaneously within 2 to 3 days. Clinically, it is characterized by abdominal distension, a lack of bowel sounds, nausea, vomiting, stomach cramps, and lack of flatus. It leads to morbidity and delays in patient discharge from the hospital, leading to an increased economic burden on the healthcare system. That's why many researchers have focused on the prevent of postoperative ileus; many studies have investigated preventive approaches such as early mobilization of the patient, adequate pain control, epidural anaesthesia, hot pack therapy, motility agents such as metoclopramide, and alvimopan. Although POI incidence has lower after the laparoscopic surgery it remains a major problem during the postoperative period.
Recent studies demonstrated that coffee consumption is associated with improved gastrointestinal function without worsening of postoperative morbidity for both open and laparoscopic surgery. However, until now, no studies investigating the effect of postoperative coffee consumption at laparoscopic gynecologic surgery. Therefore, the investigators performed a randomized controlled trial to assess whether coffee consumption accelerates the recovery of bowel function after laparoscopic gynecologic surgery.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mugla, Turkey, 48000
- Mugla Sıtkı Kocman University Education and Research Hospital
-
Muğla, Turkey, 35460
- Kemal Güngördük
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients underwent total laparoscopic hysterectomy with or without additional surgery *salpingo-oophorectomy,
- salpingectomy,
- pelvic and/or para-aortic lymphadenectomy
Exclusion Criteria:
- patients with hypersensitivity or allergy to caffeine/ coffee,
- patients with thyroid disease,
- patients with inflammatory bowel disease,
- patients with compromised liver function,
- patients with clinically significant cardiac arrhythmia,
- patients with chronic constipation (defined as < 2 bowel movements per week),
- patients with a history of abdominal bowel surgery,
- patients with previous abdominal irradiation,
- the requirement for postoperative care in the intensive care unit >24 hours postoperatively,
- the requirement for nasogastric tube drainage beyond the end of the surgery
- requirement bowel anastomosis
- conversion to laparotomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control group
the control group received 3 cups hot water on the 6th, 12th and 18th hours after the operation
|
|
Experimental: study group
drank 3 cups of caffeinated coffee on the 6th, 12th and 18th hours after the operation.
|
All patients were asked to drink the entire 150-mL amounts within 20 minutes under the supervision of a nurse or doctor.
Patients were free to drink any amount of water but no more coffee, black tea, or other forms of caffeine, such as soda.
Coffee and hot water were prepared with a conventional coffee machine (Nescafe Alegria; 100 g caffeine; Nestlé.
Gatwick, United Kingdom).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to first passage of flatus
Time Frame: 72 hours
|
Patients were checked hourly by auscultation for bowel sounds and were asked to note the time of first flatus and defecation and to inform the observing nurses or assistant.The time to the first passage of flatus after surgery during routine postoperative care.
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to tolerance of a solid diet
Time Frame: 72 hours
|
The time to tolerance of a solid diet was measured from the end of surgery which was defined as when the patients woke up from anesthesia until the patient tolerated the intake of solid food (any food that required chewing) without vomiting or experiencing significant nausea within 4 hours after the meal and without reversion to enteral fluids only
|
72 hours
|
Time to the first bowel movement
Time Frame: 72 hours
|
The time to the first bowel movement was defined as the time to the first audible bowel sound during routine postoperative care.
|
72 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- mugla-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Ileus
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingPostoperative IleusBelgium
-
West China HospitalCompletedPostoperative IleusChina
-
Hadassah Medical OrganizationCompleted
-
li xiongUnknown
-
Jinling Hospital, ChinaCompletedPostoperative IleusChina
-
Services Hospital, LahoreCompletedPostoperative IleusPakistan
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedPostoperative IleusBelgium
-
Gabriele Baldini, MD, MSc, Assistant ProfessorCompleted
-
Benazir Bhutto Hospital, RawalpindiCompletedPostoperative Ileus.Pakistan
Clinical Trials on coffee
-
University Hospital HeidelbergUnknown
-
University of California, San FranciscoRecruiting
-
Mondelēz International, Inc.St. Luke's-Roosevelt Hospital CenterCompleted
-
University of British ColumbiaUnknownInflammatory Response | Cognitive Function | Leukocytosis | TriglyceridesCanada
-
Eastern Mediterranean UniversityCompletedCardiovascular DiseasesCyprus
-
Cedars-Sinai Medical CenterCompletedPostoperative IleusUnited States
-
University of ChileSociété des Produits Nestlé (SPN)Completed
-
Assistance Publique - Hôpitaux de ParisRecruitingADCY5-related DyskinesiaFrance
-
West German Center of Diabetes and HealthTchibo GmbHCompleted
-
Massachusetts Eye and Ear InfirmaryCompleted